Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma.
BACKGROUND: We investigated cell cycle kinetics of nodular lesions in cirrhosis to differentiate hepatocellular carcinoma (HCC) from its precursor lesions. METHODS: Twelve small HCC, 10 regenerative (RN), six large regenerative (LRN), and five dysplastic nodules (DN), identified in explant cirrhoti...
主要な著者: | Quaglia, A, McStay, M, Stoeber, K, Loddo, M, Caplin, M, Fanshawe, T, Williams, G, Dhillon, A |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2006
|
類似資料
-
Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
著者:: Dudderidge, T, 等
出版事項: (2005) -
DNA replication licensing and cell cycle kinetics of normal and neoplastic breast.
著者:: Shetty, A, 等
出版事項: (2005) -
Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
著者:: He, Michelle J., 等
出版事項: (2022) -
Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
著者:: Yelena Lapidot, 等
出版事項: (2020-06-01) -
Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
著者:: Michelle Junyi He, 等
出版事項: (2022-11-01)